SCHEMBL28690762

SCHEMBL28690762

C#CCN(Cc1ccccc1)Cc1ccc(C(=O)NO)cc1

nearest known ligand 0.61

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 14/20 0.61
▸ HDAC6 Q9UBN7 14/20 0.61
▸ HDAC8 Q9BY41 8/20 0.61
▸ HDAC3 O15379 2/20 0.61
▸ HDAC7 Q8WUI4 2/20 0.61
▸ HDAC10 Q969S8 2/20 0.61
▸ HDAC2 Q92769 3/20 0.55
▸ HDAC11 Q96DB2 2/20 0.52
▸ HDAC4 P56524 2/20 0.52
▸ HDAC9 Q9UKV0 1/20 0.52
▸ HDAC5 Q9UQL6 1/20 0.52
▸ PYCR1 P32322 1/20 0.51
▸ KCNH2 Q12809 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28696676 0.87 HDAC6 (0.60) HDAC1HDAC6HDAC8HDAC3HDAC7
SCHEMBL28690802 0.87 HDAC6 (0.56) HDAC1HDAC6HDAC8HDAC3HDAC7
SCHEMBL28697641 0.87 HDAC6 (0.56) HDAC1HDAC6HDAC8HDAC3HDAC7
SCHEMBL28673090 0.87 HDAC6 (0.50) HDAC1HDAC6HDAC8HDAC3HDAC7
SCHEMBL28697606 0.86 HDAC6 (0.52) HDAC1HDAC6HDAC8HDAC3HDAC7
SCHEMBL28688140 0.86 HDAC1 (0.58) HDAC1HDAC6HDAC8HDAC3HDAC7
SCHEMBL28697601 0.86 HDAC6 (0.53) HDAC1HDAC6HDAC8HDAC3HDAC7
SCHEMBL28688145 0.86 HDAC6 (0.52) HDAC1HDAC6HDAC8HDAC3HDAC7
SCHEMBL28674189 0.86 HDAC6 (0.55) HDAC1HDAC6HDAC8HDAC3HDAC7
SCHEMBL28696862 0.85 HDAC6 (0.51) HDAC1HDAC6HDAC8HDAC3HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113956182-B HDAC/MAO-B dual inhibitor and preparation and application thereof 杭州师范大学 2023-11-17 — — CN disclosed
CN-113956182-A HDAC/MAO-B dual inhibitor and preparation and application thereof 杭州师范大学 2022-01-21 — — CN disclosed
Send feedback